Screening for prostate cancer in the US? Reduce the harms and keep the benefit. (Q51063097)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25123412 AND SRC:MED&resulttype=core&format=json

12 March 2020

title

Screening for prostate cancer in the US? Reduce the harms and keep the benefit (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25123412 AND SRC:MED&resulttype=core&format=json

12 March 2020

author name string

Tiago M de Carvalho

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25123412 AND SRC:MED&resulttype=core&format=json

12 March 2020

Eveline A M Heijnsdijk

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25123412 AND SRC:MED&resulttype=core&format=json

12 March 2020

Harry J de Koning

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25123412 AND SRC:MED&resulttype=core&format=json

12 March 2020

language of work or name

English

0 references

publication date

1 September 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25123412 AND SRC:MED&resulttype=core&format=json

12 March 2020

number of pages

8

1 reference

International Journal of Cancer

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25123412 AND SRC:MED&resulttype=core&format=json

12 March 2020

volume

136

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25123412 AND SRC:MED&resulttype=core&format=json

12 March 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25123412 AND SRC:MED&resulttype=core&format=json

12 March 2020

page(s)

1600-1607

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25123412 AND SRC:MED&resulttype=core&format=json

Mortality results from a randomized prostate-cancer screening trial

12 March 2020

cites work

1 reference

Prostate-cancer mortality at 11 years of follow-up

21 January 2018

1 reference

Risk stratification in prostate cancer screening.

21 January 2018

1 reference

Systematic review of complications of prostate biopsy

21 January 2018

1 reference

Quality-of-life effects of prostate-specific antigen screening.

21 January 2018

1 reference

Influence of study features and methods on overdiagnosis estimates in breast and prostate cancer screening

21 January 2018

1 reference

Overdiagnosis and overtreatment of prostate cancer

21 January 2018

1 reference

Cost-effectiveness of Prostate Health Index for prostate cancer detection

21 January 2018

1 reference

Prostate cancer screening strategies with re-screening interval determined by individual baseline prostate-specific antigen values are cost-effective

21 January 2018

1 reference

Comparative effectiveness of alternative prostate-specific antigen--based prostate cancer screening strategies: model estimates of potential benefits and harms

21 January 2018

1 reference

Predicting prostate cancer many years before diagnosis: how and why?

21 January 2018

1 reference

Is additional testing necessary in men with prostate-specific antigen levels of 1.0 ng/mL or less in a population-based screening setting? (ERSPC, section Rotterdam).

21 January 2018

1 reference

Incidence of prostate cancer after termination of screening in a population-based randomised screening trial

21 January 2018

1 reference

Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer.

21 January 2018

1 reference

Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context

21 January 2018

1 reference

The prostate cancer conundrum revisited: treatment changes and prostate cancer mortality declines

21 January 2018

1 reference

How does early detection by screening affect disease progression? Modeling estimated benefits in prostate cancer screening

21 January 2018

1 reference

Modeling Disease Progression with Longitudinal Markers

21 January 2018

1 reference

Reconstructing PSA testing patterns between black and white men in the US from Medicare claims and the National Health Interview Survey

21 January 2018

1 reference

Prostate biopsy following a positive screen in the prostate, lung, colorectal and ovarian cancer screening trial

21 January 2018

1 reference

21 January 2018

Overdiagnosis in cancer

1 reference

Empirical estimates of prostate cancer overdiagnosis by age and prostate-specific antigen

21 January 2018

1 reference

Mean sojourn time, overdiagnosis, and reduction in advanced stage prostate cancer due to screening with PSA: implications of sojourn time on screening

21 January 2018

1 reference

Active surveillance for prostate cancer: progress and promise

21 January 2018

1 reference

Gleason score, age and screening: Modeling dedifferentiation in prostate cancer

21 January 2018

1 reference

12 December 2020

Number of screens for overdetection as an indicator of absolute risk of overdiagnosis in prostate cancer screening

1 reference

12 December 2020

Commentary on "prostate cancer screening in the randomized prostate, lung, colorectal, and ovarian cancer screening trial: Mortality results after 13 years of follow-up". Andriole GL, Crawford ED, Grubb RL III, Buys SS, Chia D, Church TR, Fouad MN,

1 reference

12 December 2020

Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40-55 and long term risk of metastasis: case-control study

1 reference

12 December 2020

Individualized estimates of overdiagnosis in screen-detected prostate cancer

1 reference

12 December 2020

Identifiers

DOI

10.1002/IJC.29136

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25123412 AND SRC:MED&resulttype=core&format=json

12 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25123412 AND SRC:MED&resulttype=core&format=json

12 March 2020

PubMed publication ID

25123412

1 reference